Over the past few years, inexpensive data storage coupled with advancements in supercomputers and artificial intelligence (AI) analytics have allowed the exploitation of population data in ways that megalomaniac technocrats and totalitarian dictators could only have dreamed of just a decade or two ago.
US government advisers in March said that Chinese firm BGI Group was constructing a vast bank of genomic data that, combined with AI tools, would allow China to monopolize the global pharmaceutical industry, “build” genetically enhanced soldiers and — most concerning of all — engineer pathogens to empower ethnically targeted bioweapons.
Reuters on Wednesday published a special report on BGI Group’s gene harvesting that makes for chilling reading.
BGI Group’s prenatal test, branded NIFTY (Non-Invasive Fetal TrisomY) is one of the most popular in the world and has been used to harvest genetic data from millions of women in at least 52 countries, the report says. The company reportedly stores and reanalyzes leftover blood samples and genetic data from the tests — taken by more than 8 million women around the world — to detect abnormalities such as Down syndrome in fetuses.
A review of scientific papers and company statements by Reuters found that the tests capture genetic information about the mother, which is what appears to be of interest to the Chinese military.
The report says that BGI Group has collaborated with the Chinese People’s Liberation Army (PLA) on at least a dozen studies since 2010, including conducting research into population traits. One such study used a PLA military supercomputer to reanalyze gene data collected from NIFTY tests to isolate specific character traits in Tibetan and Uighur minorities.
The Reuters investigation found that genomic data collected by BGI Group from women outside of China have been stored in a gene database funded by the Chinese government.
While some of the studies could have benign medical uses — such as tracking the effect of hepatitis B on different ethnicities to develop enhanced antiviral treatments — the PLA’s involvement should be a red flag, especially given China’s openly stated doctrine of “civil-military fusion.”
The PLA could use the vast database to find genetic vulnerabilities in a population — perhaps an adversary nation. A particular susceptibility to disease could be identified and then targeted with a genetically tailored bioweapon. The collaboration of civilian and PLA scientists on “gain of function” coronavirus experiments at the Wuhan Institute of Virology is well-documented.
China is known to have initiated a biowarfare research program in the early 1950s. In 1984, Beijing signed the Biological Weapons Convention, a disarmament treaty prohibiting signatory nations from developing, acquiring or stockpiling biological and toxin weapons, but the US intelligence community regardless continues to be concerned about PLA research on bioweapons.
A senior US Department of State official, speaking anonymously to China analyst and author Bill Gertz last year, said that classified Chinese research on biological warfare includes engineered weapons designed to attack specific ethnic groups with pathogens.
“We are looking at potential biological experiments on ethnic minorities,” the source said.
BGI Group’s collaboration with the PLA could be the tip of the iceberg. Who knows if other Chinese companies are also harvesting gene data from around the world?
Taiwan and other nations must take the threat seriously and direct resources to discovering whatever they can about the capabilities and intent of what appears to be a covert Chinese bioweapons program — before it is too late.
A Facebook post by Taipei Mayor Chiang Wan-an (蔣萬安) earlier this month achieved record levels of engagement — although perhaps inadvertently. In it, he attacked Democratic Progressive Party (DPP) Legislator and Taipei mayoral candidate Puma Shen (沈伯洋) for an op-ed published in 2014 discussing drug harm reduction policies. In attempting to stir up fear with talk of community centers, drugs and needles, Chiang’s comment section exploded. More than 100,000 comments poured in within the first two hours; more than 330,000 after the first 12; and more than 400,000 by noon the following day. Rather embarrassingly, many commenters made a point
Southeast Asian food delivery platform Grab Holdings Ltd in March applied to acquire Delivery Hero SE’s Foodpanda operations in Taiwan, with the Fair Trade Commission (FTC) scheduled to announce its decision on Oct. 27. On the surface, the deal is a business merger — but in substance, it involves personal data, national geospatial information and digital sovereignty. It cannot be assessed solely in terms of market share and price competition. Grab has extensive and long-standing connections to Chinese capital. In 2015, Chinese ride-hailing firm Didi Chuxing and China Investment Corp, a sovereign wealth fund, invested in Grab. Grab invested in Chinese autonomous-driving
The official English name for Democratic Progressive Party (DPP) Legislator and Taipei mayoral candidate Puma Shen’s (沈伯洋) campaign is “the Taipei Current.” It comes from the Chinese term yangliu (洋流), a direct translation of which would be “ocean current,” using the last character of Shen’s name, yang (洋, “ocean”). The Chinese term is a reference to the 2018 campaign for Kaohsiung mayor that swept a hitherto marginal player within the Chinese Nationalist Party (KMT), Han Kuo-yu (韓國瑜), who is now legislative speaker, whose successful campaign then was termed the “Han Wave” (韓流). Shen’s usage of the Chinese term is intentional.
The most troubling message coming out of Washington for Taipei is not any single statement but the cumulative effect of a series of signals suggesting that US President Donald Trump is rethinking Taiwan’s strategic value while viewing the US-China relationship through the lens of a transactional great-power bargain. The danger behind Trump’s new softness toward Beijing is a potential US-China bargain that undermines Taiwan’s core interests. During Chinese President Xi Jinping’s (習近平) recent state visit to Washington, Trump and Xi appeared to rewrite the history of World War II. In a Sept. 25 fact sheet on Xi’s visit, the White House said,